Doxazosin Tablet
Product Images NDC 68788-8412

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 68788-8412). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Timelinedescription Automatically Generated (2110eec5 949d 4718 Ad6d 3629e5db8a07 00)

This is a medication package of Doxazosin Tablets 4mg, a generic substitute for Cardura. Each tablet contains Doxazosin Mesylate, equivalent to 4 mg of doxazosin. The package is intended only for the patient for whom it was prescribed and cannot be transferred by law. The manufacturer is Apotex and Apolox, and the package contains 2x30 tablets. The lot number, batch number, and production number are also listed, along with the expiration date.*

FDA Label Image

Doxazosin-structure.jpg (Doxazosin Structure)

FDA Label Image

Figure1.jpg (Figure1)

FDA Label Image

Table3.jpg (Table3)

This text contains data from different clinical trials regarding the effectiveness of doxazosin in treating benign prostatic hyperplasia (BPH). The trials include measurements of maximum flow rate and symptom score in patients treated with either doxazosin or a placebo. The results show that doxazosin is more effective than the placebo in improving symptoms and increasing maximum flow rate. The text includes information about the number of patients and the duration of the trials, as well as details about the dosages given.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.